Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: University Hospitals Cleveland Medical Center, Case Western Reserve University, University of California, San Francisco, University of Miami, Sylvester Comprehensive Cancer Center, University College Hospital, University College London Hospitals NHS Foundation Trust, Medical College of Wisconsin, Medical University of South Carolina, Washington University in St. Louis, Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust, Northside Hospital, Istituto Oncologico della Svizzera Italiana, University of Bologna, Humanitas University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3094925101